283 related articles for article (PubMed ID: 6372157)
1. Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C.
Navran SS; Romstedt K; Chang J; Miller DD; Feller DR; Huzoor-Akbar
Thromb Res; 1984 Mar; 33(5):499-510. PubMed ID: 6372157
[TBL] [Abstract][Full Text] [Related]
2. Human platelet activation by bacterial phospholipase C: mechanism of inhibition by flurazepam.
Anwer K; Wallace D; Romstedt K; Huzoor-Akbar
Thromb Res; 1988 Jan; 49(2):225-39. PubMed ID: 2896397
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.
Akbar H; Navran SS; Chang J; Miller DD; Feller DR
Thromb Res; 1982 Aug; 27(4):405-17. PubMed ID: 6293114
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.
Bleasdale JE; Thakur NR; Gremban RS; Bundy GL; Fitzpatrick FA; Smith RJ; Bunting S
J Pharmacol Exp Ther; 1990 Nov; 255(2):756-68. PubMed ID: 2147038
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
7. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and investigation of the beta-adrenoceptor agonist and platelet antiaggregatory properties of 1,7,8-trisubstituted 2,3,4,5-tetrahydro-1H-2-benzazepine analogues of trimetoquinol.
Clark MT; Chang J; Navran SS; Huzoor-Akbar ; Mukhopadhyay A; Amin H; Feller DR; Miller DD
J Med Chem; 1986 Feb; 29(2):181-5. PubMed ID: 2869145
[TBL] [Abstract][Full Text] [Related]
10. Possible regulation of phospholipase C activity in human platelets by phosphatidylinositol 4',5'-bisphosphate.
Graff G; Nahas N; Nikolopoulou M; Natarajan V; Schmid HH
Arch Biochem Biophys; 1984 Jan; 228(1):299-308. PubMed ID: 6320736
[TBL] [Abstract][Full Text] [Related]
11. Inositol phospholipid metabolism in human platelets stimulated by ADP.
Vickers JD; Kinlough-Rathbone RL; Packham MA; Mustard JF
Eur J Biochem; 1990 Oct; 193(2):521-8. PubMed ID: 2171937
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane associated phospholipase C from human platelets: synergistic stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis by thrombin and guanosine 5'-O-(3-thiotriphosphate).
Baldassare JJ; Henderson PA; Fisher GJ
Biochemistry; 1989 Jan; 28(1):56-60. PubMed ID: 2539864
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation by unsaturated fatty acids through interference with a thromboxane-mediated process.
Sato T; Nakao K; Hashizume T; Fujii T
Biochim Biophys Acta; 1987 Nov; 931(2):157-64. PubMed ID: 3663714
[TBL] [Abstract][Full Text] [Related]
14. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.
Faili A; Emadi S; Vargaftig BB; Hatmi M
Br J Haematol; 1994 Sep; 88(1):149-55. PubMed ID: 7803237
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C.
Simon MF; Chap H; Douste-Blazy L
Biochim Biophys Acta; 1986 Feb; 875(2):157-64. PubMed ID: 3080024
[TBL] [Abstract][Full Text] [Related]
17. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets.
Ryningen A; Olav Jensen B; Holmsen H
Biochim Biophys Acta; 1998 Nov; 1394(2-3):235-48. PubMed ID: 9795233
[TBL] [Abstract][Full Text] [Related]
18. Involvement of phospholipase C-gamma2 in activation of mitogen-activated protein kinase and phospholipase A2 by zooxanthellatoxin-A in rabbit platelets.
Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y
J Pharmacol Exp Ther; 1997 Jul; 282(1):496-504. PubMed ID: 9223592
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
Nunez D; Randon J; Gandhi C; Siafaka-Kapadai A; Olson MS; Hanahan DJ
J Biol Chem; 1990 Oct; 265(30):18330-8. PubMed ID: 2170407
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
Huzoor-Akbar ; Anwer K
Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
